Arrowstreet Capital
PRNB

Arrowstreet Capital’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Arrowstreet Capital’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-83,065
Closed -$4.97M – 2639
2020
Q2 		$4.97M Buy
83,065
+42,200
+103% +$2.61M 0.01% 1063
2020
Q1 		$2.43M Sell
40,865
-13,484
-25% -$786K 0.01% 990
2019
Q4 		$2.98M Buy
+54,349
New +$2.03M 0.01% 1010

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Arrowstreet Capital's PRNB Position: Q3 2020 in Review

Arrowstreet Capital sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 83,065 shares — an estimated $4.97M sold.

Arrowstreet Capital first reported a position in PRNB in Q4 2019 and held it in 3 quarters. The position peaked at $4.97M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Arrowstreet Capital reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 83,065 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $4.97M.
  • Arrowstreet Capital first reported a position in Principia Biopharma Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • Arrowstreet Capital's Principia Biopharma Inc. Common Stock position peaked at $4.97M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.